The global astaxanthin market is entering a new phase of accelerated growth, underpinned by technological innovation and a decisive shift toward natural, sustainable health solutions.
According to a recent report from Allied Market Research, the market, valued at $0.8bn in 2023, is projected to reach $1.6bn by 2033, expanding at a steady CAGR of approximately 8%.
At the heart of this growth is the convergence of preventive healthcare trends and production breakthroughs.
As chronic diseases such as cardiovascular disorders, diabetes and inflammatory conditions become more prevalent worldwide, consumers are increasingly seeking antioxidant-rich supplements to support long-term wellness.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.